GlassScriptPhysician profile
Brian R Heaps
NPI 1164740320
$12,673.26
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,844 · 2020: $323 · 2021: $1,014 · 2022: $1,314 · 2023: $809 · 2024: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $3,760.81 | 2019 | |
| Recibio, INC. | $3,600.00 | 2019 | |
| Exeltis, USA INC. | $1,084.46 | 2019-2024 | Slynd |
| Abbvie INC. | $912.85 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $318.90 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $262.86 | 2019-2023 | |
| Evofem Biosciences, INC. | $225.32 | 2021-2023 | Phexxi |
| Lupin INC. | $211.57 | 2019-2021 | |
| Ethicon US, LLC | $172.53 | 2022-2024 | N/A |
| Myovant Sciences INC. | $148.66 | 2021-2022 | |
| Olympus America INC. | $148.48 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $141.37 | 2019-2021 | |
| Avion Pharmaceuticals | $128.28 | 2019-2022 | |
| Astellas Pharma US INC | $124.55 | 2022-2024 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $121.09 | 2022-2023 | Accrufer |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $104.09 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Medtronic, INC. | $97.42 | 2022-2023 | Truclear |
| Acessa Health INC. | $97.27 | 2019 | |
| Baxter Healthcare | $88.22 | 2019-2024 | Perclot |
| Coopersurgical, INC. | $86.73 | 2022 | |
| Sumitomo Pharma America, INC. | $86.47 | 2023-2024 | Myfembree |
| Mylan Pharmaceuticals INC. | $80.71 | 2019-2022 | |
| Agile Therapeutics, INC. | $77.90 | 2022-2023 | Twirla |
| Smith+Nephew, INC. | $75.55 | 2019-2023 | Pico 7 |
| Therapeuticsmd, INC. | $63.49 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $62.20 | 2019-2022 | |
| Organon LLC | $41.30 | 2021 | |
| Exact Sciences Corporation | $39.61 | 2023 | Cologuard Collection Kit |
| Davol INC. | $35.29 | 2023 | Arista Ah Flexitip |
| Millicent US INC | $34.88 | 2023-2024 | Intrarosa, Femring |
| Meditrina | $31.55 | 2022 | |
| Scynexis, INC. | $31.15 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.68 | 2019 | |
| Gynesonics, INC. | $23.19 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Janssen Pharmaceuticals, INC | $19.05 | 2021 | |
| Pfizer INC. | $18.63 | 2023 | |
| Optumhealth Care Solutions, LLC | $17.21 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Vertical Pharmaceuticals, LLC | $15.52 | 2019 | |
| Allergan, INC. | $15.41 | 2020 | |
| Covidien LP | $14.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.83 | 2019 | |
| Kerecis Limited | $9.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Heaps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.